Collaboration Funding Innovation Press Release Regulatory
Revolutionising biomedical data sharing and AI-driven healthcare solutions
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Investment Press Release
hemotune makes a significant step forward: advancing into clinical trials after completing CHF 14 million Series B2 round
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Diversity Hemex Team
We welcome David to the team!
HEMEX contribution for preparing tomorrow's leaders!
Continue reading
Investment Press Release
Driving the future of non-surgical endometriosis diagnosis: Hera Biotech acquires Scailyte’s endometriosis diagnostic assets
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Hemex Team
Graphic Design Internship at HEMEX
Noémie is a student at FMS Muttenz. She completed a two-week internship at HEMEX focusing [...]
Continue reading
Congratulations to our portfolio company Scailyte for being selected among the 12 finalists for the Nature Research Spinoff Prize. The Spinoff Prize is a new Nature Research Award for early-stage university spinoff companies from around the world. The Award has been established by Nature Research in partnership with Merck to showcase and celebrate global excellence in […]
Our portfolio company ARTIDIS announces today promising data from their first prospective study conducted at the Breast Center in Basel, Switzerland. The spin-off from the Biozentrum at the University of Basel has succesfully developed the first nanomechanical biomarker for cancer diagnosis and treatment optimization. HEMEX AG is a privately-owned Swiss investment and consulting company headquartered […]
Numerous Swiss and European start-ups and SME’s applied for this year’s Swiss Innovation Challenge! In the 1st pitching round, 100 innovative participants presented their projects in front of a competent jury. Selected start-ups also benefit from a comprehensive support platform with individual coaching, tailored education, and mentoring, as well as get access to potential investors […]
Funding, Innovation
“100 fürs Baselbiet” (100 for Baselland) Supports the Federal Program for Innovative Start-Ups
The “100 fürs Baselbiet” (1004BB) initiative was launched in November 2019 by the three partners University of Applied Sciences Northwestern Switzerland (Fachhochschule Nordwestschweiz, FHNW), the State Bank of the Canton of Basel-Landschaft (Basellandschaftliche Kantonalbank, BLKB) and the Canton of Baselland. This popular initiative among start-ups in the region has been operational since the beginning of […]
Four promising Swiss start-ups pitched their ventures from the HEMEX Incubator to an online group of investors. LiVET develops and produces rapid molecular point-of-care diagnostic tests for veterinary use. Based on their proprietary platform technology, veterinarians are able to diagnose infectious diseases on-site and within only 30 minutes for up to 16 samples at […]
After the Top 16 was announced by the W.A. De Vigier in March, now the Top 10 finalists for this year’s Award are published. The winners will be announced in early June! We are particularly proud to see our portfolio company Annaida Technologies in the Top 10 and wish them and all the Top 10 Startups […]
